Genworth Financial remains a Buy, boosted by strong Enact Holdings stake and recent cash flow gains.

Genworth Financial is rated a Buy due to its 81% ownership of Enact Holdings, which supports its valuation despite market concerns over legacy insurance liabilities. The company trades below both its book value and the market value of its Enact stake. Recent Q2 2026 results show strong cash generation from Enact, enabling Genworth to pursue aggressive share buybacks and reduce debt, with $500 million newly authorized for repurchases. Additionally, a favorable $750 million UK court ruling may provide a tax-free windfall, supporting further capital returns and investment in CareScout, although risks remain from legacy insurance blocks and reliance on Enact's performance.